MedTrace Logo

Preoperative Cardiology Consultation and the Incidence of Major Adverse Cardiac Events（MACE）

NCT06884436 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22000

Last updated 2025-03-28

No results posted yet for this study

Summary

This cohort study aims to determine when preoperative cardiology consultation is needed to reduce the incidence of major adverse cardiac events (MACE) in elderly patients undergoing non-cardiac surgery. The study collected data on elderly patients with preoperative electrocardiogram (ECG) results who underwent non-cardiac surgery. It was conducted at the First Medical Center of the Chinese People's Liberation Army General Hospital from January 2015 to August 2019. MACE was defined as a composite event occurring within 30 days postoperatively, including acute myocardial infarction, unstable angina, heart failure, new-onset severe arrhythmias, non-fatal cardiac arrest, and cardiac death. Data were extracted using structured query language (SQL) and reviewed by three experienced clinicians. Preoperative cardiology consultation was considered as a mediating variable. By modeling, the confounding factors and risk factors for MACE were identified, and the impact of cardiology consultation as a mediating factor on the incidence of postoperative MACE was evaluated. Additionally, the study aimed to identify which categories of ECG findings necessitate cardiology consultation to reduce the incidence of adverse cardiac events, thereby optimizing the cardiology consultation process.

Conditions

  • Major Adverse Cardiac Events
  • Acute Myocardial Infarction (AMI)
  • Cardiac Death, Sudden
  • Cardiac Arrest (CA)
  • Arrhythmia, Cardiac
  • Heart Failure (HF)
  • Unstable Angina (UA)

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Jingsheng Lou, PhD & MD · The First Medical Center, Chinese PLA General Hospital

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-08-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06884436 on ClinicalTrials.gov